Clinical Trial Update: AVANTI - Avelox® in Acute Exacerbations of chroNic bronchiTIs

View source ↗

Summary

A clinical trial evaluating moxifloxacin (Avelox) for acute exacerbations of chronic bronchitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis

Drugs mentioned

• Avelox (moxifloxacin)

Snippet

Sponsor: Bayer | Conditions: Bronchitis, Chronic | Status: COMPLETED